Role of novel immunotherapy combinations in the management of advanced-stage hepatocellular carcinoma

Nat Rev Clin Oncol. 2025 Sep;22(9):625-626. doi: 10.1038/s41571-025-01055-5.

Josep M Llovet^{1

2

3}

¹ Mount Sinai Liver Cancer Program, Divisions of Liver Diseases, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. josep.llovet@mountsinai.org.
² Liver Cancer Translational Research Group, Liver Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. josep.llovet@mountsinai.org.
³ Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. josep.llovet@mountsinai.org.

No abstract available